At the annual American Society of Clinical Oncology conference, Christopher Ryan, M.D., presents results of a study on the drug everolimus. The findings suggest the drug can improve outcomes in those with high-risk kidney cancer.

Peter Graven, Ph.D., says, “Symptoms are high right now – there is actually quite a bit of infection going on – but the really good news is that our hospitalizations and deaths are much lower than we’ve ever seen given that much infection.”

A report on OHSU experts’ June 3 testimony before the Oregon House Interim Committee on COVID-19 Response. Dawn Nolt, M.D., and Eliza Hayes Bakken, M.D., discuss pediatric vaccinations, Peter Graven, Ph.D., describes what his modeling predicts about the pandemic’s future, and Eric Herman, M.D., and Jordan Anderson, D.O. discuss long COVID-19

News outlets report on OHSU experts’ June 3 testimony before the Oregon House Interim Committee on COVID-19 Response. Dawn Nolt, M.D., and Eliza Hayes Bakken, M.D., discuss pediatric vaccinations, Peter Graven, Ph.D., describes what his modeling predicts about the pandemic’s future, and Eric Herman, M.D., and Jordan Anderson, D.O. discuss long COVID-19.

– Walter Dawson, D.Phil., is named a 2022 Fellow for Social Research, Policy, and Practice by The Gerontological Society of America.

Matt Riddle, M.D., is named to clinical advisory board for Anji Pharma, according to a news release from the company.

Story about a drug-coated balloon catheter quotes Joaquin Cigarroa, M.D., as a member of the Food and Drug Administration’s Circulatory System Devices Panel.

Link Oregon, a consortium that includes OHSU, has joined a network expanding worldwide wireless service, according to a news release by Internet2.

Report on security in light of new spasms of gun violence at health centers in Oklahoma and Ohio.